The first vaccine against Ebola, discovered and produced in Italy – Footprint Unika

Discovered and produced the vaccine Ebola. The success is thanks to the Italian research groups of the ledges of Naples, and the National Research Council of Frederick II.

The researchers involved in the project, they do know that it started mass production for the pharmaceutical industry GlaxoSmithKline, he bought the patent. The research project for the creation of a vaccine against Ebola began 14 years ago with a model of research and development unconventional. Based on this success, tells the professor, will be able to produce vaccines for other diseases, such as Hepatitis C, Malaria, Human Influenza, of bird, of tuberculosis. Okairos develop those vaccines that do not work with the induction of antibodies but on a genetic logic.

The Okairos, which was acquired last year to 250 million Euros by the multinational GlaxoSmithKline (GSK), will deliver by December about ten thousand doses of the vaccine to the World Health Organization (WHO). The GSK also is negotiating with WHO to supply, in 2015, one million doses of the vaccine at the time, appears to be the only one available.

Okairos was founded and is led by molecular biologist Richard Cortese, a Neapolitan, who left secure jobs to pursue his idea: developing vaccines but not by fragments from the entire virus, “inserted” into an adenovirus. Okairos was established in 2007 as an offshoot of Merck Sharp & amp; Dohme, one of the world’s leading pharmaceutical companies, and for five years, when perhaps the Ebola virus was known only to a few insiders, developed the vaccine research in two labs in the Ceinge. Today Okairos has its center of production of vaccines in Pomezia, where he founded a new joint venture with the IRBM Science Park in Pomezia for the development and production of the vaccine. At Ceinge, however, Okairos but still the most important part of their research, with a group of twenty researchers, many of whom Neapolitans.

“The Ceinge, which this year celebrates 30 years its inception – said Franco Salvatore – is a great example of economic and structural development of a research center. ” Born in 1984 as a small college within the University Federico II of Naples, is now a research center of excellence of international repute with over 20 research teams, 250 researchers and a business incubator. “The recipe for the success of our research – concludes Salvatore – lies in the selection of young people in a rigorous and merit-based and international collaborations that are not brain drain but fruitful exchanges of methodology of study and research.”

Share this article:

Like Tweet